Huntington Study Group Welcomes FDA Approval of New Drug for Chorea in Huntington's Disease

The Huntington Study Group together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in clinical trials for Huntington’s disease , today shares that the Phase 3...

Related Keywords

Australia ,Phoenix ,Arizona ,United States ,Canada ,New Zealand ,America ,Shari Kinel ,Andrew Feigin ,Erin Furr Stimming ,Kristin Keyes ,Huntington Disease Health Index ,Clinical Research Inc ,Drug Administration ,Technology Che ,Huntington Study Group ,University Of Rochester Medical Center ,Clinical Trials Coordination Center ,Neurocrine Biosciences Inc ,Furr Stimming ,Principal Investigator ,Chief Medical Officer ,Study Group ,Rochester Medical ,Disease Health Index ,Lancet Neurology ,Release Distributed ,Markets ,